Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma

por Fowler, Nathan H., Chen, Guifang, Lim, Stephen, Manson, Stephanie, Ma, Qiufei, Li, Frank (Yunfeng)
Publicado 2020

Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis

por Chihara, Dai, Fowler, Nathan H., Oki, Yasuhiro, Fanale, Michelle A., Nastoupil, Loretta J., Westin, Jason R., Fayad, Luis E., Neelapu, Sattva S., Cheah, Chan Yoon
Publicado 2018

Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial

por Fukuhara, Noriko, Kato, Koji, Goto, Hideki, Takeshi, Tajima, Kawaguchi, Mayu, Tokushige, Kota, Akashi, Koichi, Teshima, Takanori, Harigae, Hideo, Schuster, Stephen J., Thieblemont, Catherine, Dreyling, Martin, Fowler, Nathan
Publicado 2022

Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma

por Jain, Preetesh, Nomie, Krystle, Kotlov, Nikita, Segodin, VitaIy, Hill, Holly, Ok, Chi Young, Fetooh, Ahmed, Kanagal-Shamanna, Rashmi, Vega, Francisco, Bagaev, Alexander, Fowler, Nathan, Flowers, Christopher R., Wang, Michael
Publicado 2023

Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial

por Balasubramanian, Sriram, Hodkinson, Brendan, Schuster, Stephen J., Fowler, Nathan H., Trotman, Judith, Hess, Georg, Cheson, Bruce D., Schaffer, Michael, Sun, Steven, Deshpande, Sanjay, Vermeulen, Jessica, Salles, Gilles, Gopal, Ajay K.
Publicado 2021

B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma

por Dagogo-Jack, Ibiayi, Valiev, Ivan, Kotlov, Nikita, Belozerova, Anna, Lopareva, Aleksandra, Butusova, Anna, Samarina, Naira, Boyko, Alexandra, Xiang, Zhongmin, Johnson, Monique, Degryse, Sandrine, Keane, Florence K., Sequist, Lecia V., Lanuti, Michael, Fowler, Nathan, Mino-Kenudson, Mari, Bagaev, Alexander
Publicado 2023

Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

por Coutre, Steven E., Flinn, Ian W., de Vos, Sven, Barrientos, Jacqueline C., Schreeder, Marshall T., Wagner-Johnson, Nina D., Sharman, Jeff P., Boyd, Thomas E., Fowler, Nathan, Dreiling, Lyndah, Kim, Yeonhee, Mitra, Siddhartha, Rai, Kanti, Leonard, John P., Furman, Richard R.
Publicado 2018

Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma

por Strati, Paolo, Ahmed, Mohamed Amin, Fowler, Nathan H., Nastoupil, Loretta J., Samaniego, Felipe, Fayad, Luis E., Hagemeister, Fredrick B., Romaguera, Jorge E., Rodriguez, Alma, Wang, Michael, Westin, Jason R., Cheah, Chan, Noorani, Mansoor, Feng, Lei, Davis, Richard E., Neelapu, Sattva S.
Publicado 2020

Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma

por Nastoupil, Loretta J., Chin, Collin K., Westin, Jason R., Fowler, Nathan H., Samaniego, Felipe, Cheng, Xiaoyun, Ma, Man Chun John, Wang, Zhiqiang, Chu, Fuliang, Dsouza, Ly, Obi, Chizobam, Mims, Jennifer, Feng, Lei, Zhou, Shouhao, Green, Michael, Davis, Richard Eric, Neelapu, Sattva S.
Publicado 2022

RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma

por Zinzani, Pier Luigi, Rodgers, Thomas, Marino, Dario, Frezzato, Maurizio, Barbui, Anna Maria, Castellino, Claudia, Meli, Erika, Fowler, Nathan H., Salles, Gilles, Feinberg, Bruce, Kurukulasuriya, Nuwan C., Tillmanns, Sascha, Parche, Stephan, Dey, Debarshi, Fingerle-Rowson, Günter, Ambarkhane, Sumeet, Winderlich, Mark, Nowakowski, Grzegorz S.
Publicado 2021

Lenalidomide plus rituximab (R(2)) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial

por Becnel, Melody R., Nastoupil, Loretta J., Samaniego, Felipe, Davis, Richard E., You, M. J., Green, Michael, Hagemeister, Fredrick B., Fanale, Michelle A., Fayad, Luis E., Westin, Jason R., Wang, Michael, Oki, Yasuhiro, Forbes, Sheryl G., Feng, Lei, Neelapu, Sattva S., Fowler, Nathan H.
Publicado 2019

Incidence and predictors of Lhermitte’s sign among patients receiving mediastinal radiation for lymphoma

por Youssef, Bassem, Shank, JoAnn, Reddy, Jay P., Pinnix, Chelsea C., Farha, George, Akhtari, Mani, Allen, Pamela K., Fanale, Michelle A., Garcia, John A., Horace, Patricia H., Milgrom, Sarah, Smith, Grace Li, Nieto, Yago, Arzu, Isadora, Wang, He, Fowler, Nathan, Rodriguez, Maria Alma, Dabaja, Bouthaina
Publicado 2015

The combination of ibrutinib and rituximab demonstrates activity in first‐line follicular lymphoma

por Fowler, Nathan H., Nastoupil, Loretta, De Vos, Sven, Knapp, Mark, Flinn, Ian W., Chen, Robert, Advani, Ranjana H., Bhatia, Sumeet, Martin, Peter, Mena, Raul, Davis, Richard Eric, Neelapu, Sattva S., Eckert, Karl, Ping, Jerry, Co, Melannie, Beaupre, Darrin M., Neuenburg, Jutta K., Palomba, M. Lia
Publicado 2020

Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy

por Sheu, Tommy, Milgrom, Sarah A., Andraos, Therese Y., Gunther, Jillian R., Chi, Linda, Nastoupil, Loretta, Fowler, Nathan, Oki, Yasuhiro, Fanale, Michelle A., Fayad, Luis E., Hagemeister, Fredrick, Neelapu, Sattva S., Medeiros, L. Jeffrey, Hosing, Chitra, Nieto, Yago, Ahmed, Sairah, Alousi, Amin M., Dabaja, Bouthaina, Pinnix, Chelsea C.
Publicado 2018

Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma

por Strati, Paolo, Varma, Ankur, Adkins, Sherry, Nastoupil, Loretta J., Westin, Jason R., Hagemeister, Fredrick B, Fowler, Nathan H, Lee, Hun J., Fayad, Luis E., Samaniego, Felipe, Ahmed, Sairah, Chen, Yiming, Horowitz, Sandra, Arafat, Sara, Johncy, Swapna, Kebriaei, Partow, Mulanovich, Victor Eduardo, Heredia, Ella Ariza, Neelapu, Sattva S.
Publicado 2020

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma

por Leonard, John P., Trneny, Marek, Izutsu, Koji, Fowler, Nathan H., Hong, Xiaonan, Zhu, Jun, Zhang, Huilai, Offner, Fritz, Scheliga, Adriana, Nowakowski, Grzegorz S., Pinto, Antonio, Re, Francesca, Fogliatto, Laura Maria, Scheinberg, Phillip, Flinn, Ian W., Moreira, Claudia, Cabeçadas, José, Liu, David, Kalambakas, Stacey, Fustier, Pierre, Wu, Chengqing, Gribben, John G.
Publicado 2019

The risk of central nervous system relapses in patients with peripheral T-cell lymphoma

por Chihara, Dai, Fanale, Michelle A., Miranda, Roberto N., Noorani, Mansoor, Westin, Jason R., Nastoupil, Loretta J., Hagemeister, Fredrick B., Fayad, Luis E., Romaguera, Jorge E., Samaniego, Felipe, Turturro, Francesco, Lee, Hun J., Neelapu, Sattva S., Rodriguez, M. Alma, Wang, Michael, Fowler, Nathan H., Davis, Richard E., Medeiros, L. Jeffrey, Oki, Yasuhiro
Publicado 2018

Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma

por Salles, Gilles, Schuster, Stephen J., Dreyling, Martin, Fischer, Luca, Kuruvilla, John, Patten, Piers E.M., von Tresckow, Bastian, Smith, Sonali M., Jiménez-Ubieto, Ana, Davis, Keith L., Anjos, Carla, Chu, Jufen, Zhang, Jie, Lobetti Bodoni, Chiara, Thieblemont, Catherine, Fowler, Nathan H., Dickinson, Michael, Martínez-López, Joaquin, Wang, Yucai, Link, Brian K.
Publicado 2022

SIRPα(+) macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab

por Marques-Piubelli, Mario L., Parra, Edwin R., Feng, Lei, Soto, Luisa Solis, Gallardo, Mariana, Gouni, Sushanth, Samaniego, Felipe, Noorani, Mansoor, Hagemeister, Fredrick B., Westin, Jason R., Lee, Hun Ju, Rodriguez, Maria A., Neelapu, Sattva S., Gunther, Jillian R., Fowler, Nathan H., Flowers, Christopher R., Wistuba, Ignacio I., Nastoupil, Loretta J., Vega, Francisco, Strati, Paolo
Publicado 2022

P1205: A LIVING PATIENT-DERIVED BIOREPOSITORY FOSTERING MICROENVIRONMENT DISSECTION IN T-CELL LYMPHOMA

por Fiore, Danilo, Vincenzo Cappelli, Luca, Zhaoqi, Liu, Kotlov, Nikita, Sorokina, Maria, Phillip, Jude, Zumbo, Paul, Yoffe, Liron, Xueshuai, Han, Pignataro, Claudia, Ghione, Paola, Fragliasso, Valentina, Condorelli, Gerolama, Foà, Robin, Brody, Joshua, Betel, Doron, Chan, Wing C, Tam, Wayne, Nikitina, Anastasie, Bagaev, Aleksander, Fowler, Nathan, Weinstock, David, Cerchietti, Leandro, Rabadan, Raul, Horwitz, Steve, Inghirami, Giorgio
Publicado 2023